• Find a pharmacy

Your child is likely protected against hepatitis B. Are you?

Hepatitis B vaccination is standard of care for infants, and now the CDC is recommending it for all adults aged 19-59*—here’s why.

There is no cure for hepatitis B—prevention is essential

Hepatitis B is an incurable liver infection caused by the hepatitis B virus. When the virus attacks the liver, the resulting health complications can be lifelong or even deadly.
New infections are highest among people aged 30-59 years
New infections are highest among people aged 30-59 years
Hepatitis B is 100x more infectious than HIV
Hepatitis B is 100x more infectious than HIV
Approximately 296 million people are living with hepatitis B†
~296 million people are living with hepatitis B

“Like eating healthy foods, exercising, and getting regular check-ups, vaccines play a vital role in keeping you healthy. Vaccines are one of the most convenient and safest preventive care measures available.”

National Foundation for Infectious Diseases

Don’t wait to get protected

Hepatitis B is incurable, but it’s also preventable. Learn about the only adult hepatitis B vaccine that offers protection with just 2 doses in 1 month—done!
Learn about HEPLISAV-B
Mom looks into daughter's eyes in kitchen
The CDC also recommends hepatitis B vaccination for adults aged ≥60 with risk factors. Adults aged ≥60 without risk factors may receive hepatitis B vaccination.Estimate based on World Health Organization data from 2019.CDC, Centers for Disease Control and Prevention.
INDICATION & Important Safety Information

INDICATION

HEPLISAV-B is indicated for the prevention of infection caused by the hepatitis B virus in adults 18 years of age and older.

IMPORTANT SAFETY INFORMATION

If you have a history of severe allergic reaction after a previous dose of any hepatitis B vaccine, or to any ingredient of HEPLISAV-B, including yeast, do not take HEPLISAV-B.

HEPLISAV-B must be given by a medical professional, who will monitor you afterwards to check for allergic reaction.

If you are immunocompromised, or receiving immunosuppressant therapy, you may have less of an immune response to HEPLISAV-B.

Some people have hepatitis B infection without being aware of it or showing any symptoms. If you already have hepatitis B present in your body, HEPLISAV-B may not prevent hepatitis B infection.

The most common side effects reported by patients within 7 days of vaccination with HEPLISAV-B were pain at the site of injection (23%-39%), tiredness (11%-17%), and headache (8%-17%).

Please see full Prescribing Information.

INDICATION & Important Safety Information

INDICATION

HEPLISAV-B is indicated for the prevention of infection caused by the hepatitis B virus in adults 18 years of age and older.

IMPORTANT SAFETY INFORMATION

If you have a history of severe allergic reaction after a previous dose of any hepatitis B vaccine, or to any ingredient of HEPLISAV-B, including yeast, do not take HEPLISAV-B.

HEPLISAV-B must be given by a medical professional, who will monitor you afterwards to check for allergic reaction.

If you are immunocompromised, or receiving immunosuppressant therapy, you may have less of an immune response to HEPLISAV-B.

Some people have hepatitis B infection without being aware of it or showing any symptoms. If you already have hepatitis B present in your body, HEPLISAV-B may not prevent hepatitis B infection.

The most common side effects reported by patients within 7 days of vaccination with HEPLISAV-B were pain at the site of injection (23%-39%), tiredness (11%-17%), and headache (8%-17%).

Please see full Prescribing Information.